These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 6436732)
1. Increase of valproate-induced hyperammonemia in normal subjects by carbohydrate intake. Warter JM; Marescaux C; Chabrier G; Rumbach L; Micheletti G; Reitzer B; Hirsch E; Imler M Neurology; 1984 Nov; 34(11):1487-9. PubMed ID: 6436732 [TBL] [Abstract][Full Text] [Related]
2. The renal origin of sodium valproate-induced hyperammonemia in fasting humans. Warter JM; Brandt C; Marescaux C; Rumbach L; Micheletti G; Chabrier G; Krieger J; Imler M Neurology; 1983 Sep; 33(9):1136-40. PubMed ID: 6412158 [TBL] [Abstract][Full Text] [Related]
3. Salicylate potentiates valproate-induced hyperammonemia in the rat. Uetrecht JP Pharmacology; 1987; 34(5):279-85. PubMed ID: 3112809 [TBL] [Abstract][Full Text] [Related]
4. Adaptation of hepatic ammonia metabolism after chronic valproate administration in epileptics treated with phenytoin. Marescaux C; Warter JM; Brandt C; Rumbach L; Micheletti G; Chabrier G; Imler M Eur Neurol; 1985; 24(3):191-5. PubMed ID: 3922765 [TBL] [Abstract][Full Text] [Related]
5. Sodium valproate-induced hyperammonemia in the rat: role of the kidney. Warter JM; Imler M; Marescaux C; Chabrier G; Rumbach L; Micheletti G; Krieger J Eur J Pharmacol; 1983 Feb; 87(2-3):177-82. PubMed ID: 6404641 [TBL] [Abstract][Full Text] [Related]
6. Decrease of valproate-induced hyperammonemia in normal subjects by lipid ingestion. Warter JM; Marescaux C; Hirsch E; Rumbach L; Micheletti G; Chabrier G; Imler M J Neurol Sci; 1985 Jul; 69(3):285-90. PubMed ID: 3928824 [TBL] [Abstract][Full Text] [Related]
7. [Role of hyperammonemia in stuporous states induced by sodium valproate]. Warter JM; Marescaux C; Rumbach L; Micheletti G; Chabrier G; Koehl C; Imler M; Collard M Rev Neurol (Paris); 1983; 139(12):753-7. PubMed ID: 6420866 [TBL] [Abstract][Full Text] [Related]
8. L-Arginine in the treatment of valproate overdose - five clinical cases. Schrettl V; Felgenhauer N; Rabe C; Fernando M; Eyer F Clin Toxicol (Phila); 2017 Apr; 55(4):260-266. PubMed ID: 28152637 [TBL] [Abstract][Full Text] [Related]
9. Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report. Mehta S; Tayabali S; Lachmann R J Med Case Rep; 2018 May; 12(1):134. PubMed ID: 29769109 [TBL] [Abstract][Full Text] [Related]
10. [Hyperammonemia in valproate therapy in children and adolescents]. Laub MC Nervenarzt; 1986 May; 57(5):314-8. PubMed ID: 3088461 [TBL] [Abstract][Full Text] [Related]
11. [Isolated hyperammonemia. A frequent consequence of treatment with sodium valproate]. Warter JM; Marescaux C; Rumbach L; Galmiche J; Micheletti G; Koehl C; Imler M Nouv Presse Med; 1981 Nov; 10(41):3406-7. PubMed ID: 6795590 [No Abstract] [Full Text] [Related]
12. [The problems of valproate therapy in severely handicapped children--valproate induced hyperammonemia and hypocarnitinemia]. Matsui K; Iwamoto H; Ohtsuki N; Kobayashi T; Miyake S; Yamada M No To Hattatsu; 1991 Jan; 23(1):32-8. PubMed ID: 1825272 [TBL] [Abstract][Full Text] [Related]
18. A case of severe hyperammonemia and unconsciousness following sodium valproate intoxication. Lee WL; Yang CC; Deng JF; Chen YF; Lin HD; Wang PH Vet Hum Toxicol; 1998 Dec; 40(6):346-8. PubMed ID: 9830696 [TBL] [Abstract][Full Text] [Related]
19. Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy. Honeycutt D; Callahan K; Rutledge L; Evans B Neurology; 1992 Mar; 42(3 Pt 1):666-8. PubMed ID: 1549234 [TBL] [Abstract][Full Text] [Related]